Drug safety: Side effects and mistakes or adverse reactions and deadly errors?

British Columbia Medical Journal

Volumn 48, Issue 7, 2006, Pages 329-333

  Carleton, Bruce C ^a,b,c   Smith, M Anne ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d Pharmaceutical Outcomes and Policy and Innovations Programme   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33750917084     PISSN: 00070556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-1205.
2. White TJ, Arakelian A, Rho JP. Counting the costs of drug-related adverse events. Pharmacoeconomics 1999;15:445-458.
3. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: Updating the cost-of-illness model. J Am Pharm Assoc (Wash) 2001;41:192-199.
4. Phillips KA, Veenstra D, Van Bebber S, et al. An introduction to cost-effectiveness and cost-benefit analysis of pharmacogenomics. Pharmacogenomics 2003;4:231-239.
5. Jonsson B. The economic impact of diabetes. Diabetes Care 1998;21 (suppl 3): C7-C10.
6. Colditz GA. Economic costs of obesity and inactivity. Med Sci Sports Exerc 1999;31:S663-S667.
7. American Heart Association. Noteworthy number from the 2002 statistical update. www.americanheart.org/presenter.jhtml ?identifier=3000364 (accessed 6 June 2006).
8. Drugs and Health Products Branch. Health Canada. Report of suspected adverse reaction due to health products marketed in Canada [form]. www.hc-sc .gc.ca/dhp-mps/medeff/report-declaration/guide/guide-ldir_indust_e.html (accessed 30 June 2005).
9. Carleton BC, Poole RL, Milton J, et al. The pediatric adverse drug reaction reporting system. J Ped Phar Prac 1999;4:284-307.
10. Office of the Inspector General. Department of Human and Health Services. Review of Food and Drug Administration's handling of adverse drug reaction reports. 14 December 1999. A-15-98-50001.
11. Hasford J, Goettler M, Munter K-H, et al. Physicians' knowledge and attitudes regarding the spontaneous reporting system for adverse drug reactions. J Clin Epidemiol 2002;55:945-950.
12. Mittman N, Knowles S, Gomez M, et al. Evaluation of the extent of under-reporting of serious adverse drug reactions. Drug Saf 2004;27:477-487.
13. Therapeutic Products Directorate. Canadian Adverse Drug Reaction Newsletter. 15(2). April 2005. www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/ carnbcei_v15n2_e.html (accessed 12 July 2005).
14. National survey on child and youth health care safety. Canadian Association of Paediatric Health Centres [PowerPoint]. www.caphc.org/ programs_patient_safety_pmrc.html.
15. Decima Research Inc. Public opinion survey on key issues pertaining to post-market surveillance of marketed health products in Canada. Ottawa, ON: Health Canada; 2003:298-302.
16. Khaled LA, Ahmad F, Brogan T, et al. Prescriptions medicine use by one million Canadian children. J Paediatr Child Health 2003;8(suppl A):6A-54A.
17. Gonzalez-Martin G, Caroca CM, Paris E. Adverse drug reactions (ADRs) in hospitalized pediatric patients. Int J Clin Pharmacol Ther 1998;36:530-533.
18. Martinez-Mir I, Garcia-Lopez M, Palop V, et al. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999;47:681-688.
19. Leeder JS. Developmental and pediatric pharmacogenomics. Pharmacogenomics 2003;4:331-341.
20. Impicciatore M. Pharmacogenomic can give children safer medicines. Arch Dis Child 2003;88:366.
21. Dartnell J, Anderson R, Chohan V, et al. Hospitalization for adverse events related to drug therapy: Incidence, avoidability and costs. Med J Aust 1996;164:659-662.
22. Joint Commission on Accreditation of Healthcare Organizations. Standards Interpretation Group. National Patient Safety Goals. www.jointcommission .org/PatientSafety/NationalPatient SafetyGoals/ (accessed 6 June 2006).
23. Shojania K, Duncan B, McDonald K, et al. Making health care safer: A critical analysis of patient safety practices. Rockville, MD. Agency for Healthcare Research and Quality: 2001.
24. Gaba D, Howard S. Patient safety: Fatigue among clinicians and the safety of patients. N Engl J Med 2002;347:1249-1255.
25. National Quality Forum. Safe practices for better healthcare. A consensus report .www.qualityforum.org/txsafeexec summ+order6-8-03 PUBLIC.pdf (accessed 11 July 2005).
26. Ruchlin H, Dubbs N, Callahan M, et al. The role of leadership in instilling a culture of safety: Lessons from the literature. J Healthc Manag 2004;49:47-59.
27. Benjamin D. Reducing medication errors and increasing patient safety: Case studies in clinical pharmacology. J Clin Pharmacol 2003;43:768-783.